Synthesis of nano liposomes used to treat cancer with personalized medicine technology based on the proteogenomics of cancer cells. 01212-16201, Teheran, Iran, September 2017, aangevraagd

G. Amoabediny; B.F. Haghiralsadat; M.N. Helder; B. Zandieh Doulabi; T. Forouzanfar

Synthesis of nano liposomes used to treat cancer with personalized medicine technology based on the proteogenomics of cancer cells. 01212-16201, Teheran, Iran, September 2017, aangevraagd

G. Amoabediny (Inventor), B.F. Haghiralsadat (Inventor), M.N. Helder (Inventor), B. Zandieh Doulabi (Inventor), T. Forouzanfar (Inventor)

Research output: Patent › Academic

Original language	English
Patent number	01212-16201
Filing date	1/09/2017
Publication status	Published - 1 Sept 2017

Cite this

@misc{cc1572666c364e669b92a49dab9cdff1,

title = "Synthesis of nano liposomes used to treat cancer with personalized medicine technology based on the proteogenomics of cancer cells. 01212-16201, Teheran, Iran, September 2017, aangevraagd",

author = "G. Amoabediny and B.F. Haghiralsadat and M.N. Helder and {Zandieh Doulabi}, B. and T. Forouzanfar",

note = "M1 - 01212-16201; 01212-16201",

year = "2017",

month = sep,

day = "1",

language = "English",

type = "Patent",

}

TY - PAT

T1 - Synthesis of nano liposomes used to treat cancer with personalized medicine technology based on the proteogenomics of cancer cells. 01212-16201, Teheran, Iran, September 2017, aangevraagd

AU - Amoabediny, G.

AU - Haghiralsadat, B.F.

AU - Helder, M.N.

AU - Zandieh Doulabi, B.

AU - Forouzanfar, T.

N1 - M1 - 01212-16201

PY - 2017/9/1

Y1 - 2017/9/1

M3 - Patent

M1 - 01212-16201

Y2 - 2017/09/01

ER -